Publications
Filters: Keyword is human [Clear All Filters]
,
“Plasmodium P36 determines host cell receptor usage during sporozoite invasion”, Elife, vol. 6, 2017.
, “Inhibitory activities of sulfated proteoglycans on chondroitin sulfate A-mediated cytoadherence of Plasmodium falciparum isolates from Thailand”, Am J Trop Med Hyg, vol. 70, no. 2, pp. 149-57, 2004.
, “Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens”, Trans R Soc Trop Med Hyg, vol. 98, no. 3, pp. 182-92, 2004.
, “A systematic overview of published antimalarial drug trials”, Trans R Soc Trop Med Hyg, vol. 98, no. 2, pp. 73-81, 2004.
, “Central role of the spleen in malaria parasite clearance”, Journal of Infectious Diseases, vol. 185, no. 10, pp. 1538-41., 2002.
, “The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 2, pp. 180-4., 2002.
, “The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos”, Ann Trop Med Parasitol, vol. 96, no. 6, pp. 553-7, 2002.
, “Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil”, Clinical Infectious Diseases, vol. 35, no. 12, pp. 1498-504., 2002.
, “Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum”, Clinical Infectious Diseases, vol. 33, no. 12, pp. 2009-16., 2001.
, “Drug resistant falciparum malaria: clinical consequences and strategies for prevention”, Drug Resistance Updates, vol. 4, no. 3, pp. 187-96., 2001.
, “Factors contributing to anemia after uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614-22., 2001.
, “Fake artesunate in southeast Asia”, Lancet, vol. 357, no. 9272, pp. 1948-50., 2001.
, “Malaria epidemic in Burundi”, Lancet, vol. 357, no. 9261, pp. 1046-7., 2001.
, “Malaria epidemiology and control in refugee camps and complex emergencies”, Annals of Tropical Medicine and Parasitology, vol. 95, no. 8, pp. 741-54., 2001.
, “Paracheck-Pf: a new, inexpensive and reliable rapid test for P. falciparum malaria”, Tropical Medicine and International Health, vol. 6, no. 2, pp. 99-101., 2001.
, “Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 651-6., 2001.
, “Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 4, pp. 285-9., 2001.
, “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545-8., 2000.
, “A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 65-9, 2000.
, “Menorrhagia caused by dengue fever”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 40, no. 3, pp. 354-5., 2000.
, “Neonatal neurological testing in resource-poor settings”, Annals of Tropical Paediatrics, vol. 20, no. 4, pp. 323-36., 2000.
, “Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria”, Antimicrob Agents Chemother, vol. 44, no. 3, pp. 697-704, 2000.
, “Plasmodium falciparum antimalarial drug susceptibility on the north- western border of Thailand during five years of extensive use of artesunate-mefloquine”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 537-44., 2000.
, “Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 6, pp. 689-93., 2000.
, “Absence of an interaction between artesunate and atovaquone-proguanil”, European Journal of Clinical Pharmacology, vol. 55, no. 6, pp. 469-74, 1999.
, “Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 4, pp. 547-55, 1999.
, “Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 1, pp. 14-21, 1999.
, “Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria”, International Journal of Clinical Pharmacology and Therapeutics, vol. 37, no. 1, pp. 58-61, 1999.
, “Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine”, Clin Pharmacokinet, vol. 37, no. 2, pp. 105-25., 1999.
, “The effects of mefloquine treatment in pregnancy”, Clinical Infectious Diseases, vol. 28, no. 4, pp. 808-15, 1999.
, “Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 936-42, 1999.
, “Genetic analysis of Plasmodium falciparum infections on the north- western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 587-93, 1999.
, “Meet my uncle”, Lancet, vol. 353, no. 9150, p. 414., 1999.
, “Naturally acquired immunity to vivax malaria”, Lancet, vol. 354, p. 162, 1999.
, “No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 61, no. 6, pp. 964-7, 1999.
, “The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand”, Antimicrob Agents Chemother, vol. 43, no. 12, pp. 2943-9, 1999.
, “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria”, Antimicrob Agents Chemother, vol. 43, no. 2, pp. 341-6, 1999.
, “Population pharmacokinetics of mefloquine in patients with acute falciparum malaria”, Clinical Pharmacology and Therapeutics, vol. 66, no. 5, pp. 472-84, 1999.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 93 Suppl 1, pp. S19-23., 1999.
, “The treatment of chloroquine-resistant malaria”, Tropical Doctor, vol. 29, no. 3, pp. 176-9, 1999.
, “Treatment of vivax malaria on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 433-8, 1999.
, “Artemisinin derivatives in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 4, pp. 430-3., 1998.
, “Artesunate and mefloquine in the treatment of uncomplicated multidrug- resistant hyperparasitaemic falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 207-11, 1998.
, “Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 6, pp. 883-8, 1998.
, “Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 45-9, 1998.
, “Consensus recommendation on the treatment of malaria in Southeast Asia”, Southeast Asian Journal of Tropical Medicine and Public Health, vol. 29, no. 2, pp. 355-60, 1998.
, “Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 562-3, 1998.
, “Health care in refugee camps”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 129-30, 1998.
, “Intrarectal artemisinin derivatives”, Medecine Tropicale, vol. 58, no. 3, pp. 63-4, 1998.
, “Maternal antibodies block malaria”, NATURE, vol. 395, no. 6705. pp. 851-2, 1998.
, “Prolongation of the QTc interval in African children treated for falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, p. 503, 1998.
, “Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 92, no. 6, pp. 643-53., 1998.
, “Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malaria”, Antimicrob Agents Chemother, vol. 42, no. 1, pp. 135-9, 1998.
, “The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 564-5, 1998.
, “Smoking cheroots reduces birthweight”, Lancet, vol. 352, no. 9139, pp. 1521-2., 1998.
, “Thanaka (Limonia acidissima) and deet (di-methyl benzamide) mixture as a mosquito repellent for use by Karen women”, Medical and Veterinary Entomology, vol. 12, no. 3, pp. 295-301, 1998.
, “Two patients with falciparum malaria and poor in vivo responses to artesunate”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 6, pp. 668-9, 1998.
, “Use of artemisinin derivatives for the control of malaria”, Medecine Tropicale, vol. 58, no. 3, pp. 45-9, 1998.
, “Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 574-7, 1997.
, “The epidemiology of severe malaria in an area of low transmission in Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 256-62, 1997.
, “Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever”, Journal of Antimicrobial and Chemotherapy, vol. 40, no. 1, pp. 91-8, 1997.
, “SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand”, Acta Tropica, vol. 67, no. 3, pp. 215-27, 1997.
, “Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay”, British Journal of Clinical Pharmacology, vol. 42, no. 5, pp. 599-604, 1996.
, “Effects of artemisinin derivatives on malaria transmissibility”, Lancet, vol. 347, pp. 1654-8, 1996.
, “Electrocardiographic monitoring in severe falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 3. pp. 266-9, 1996.
, “The epidemiology of malaria in a Karen population on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 2, pp. 105-11, 1996.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand.”, Lancet, vol. 348, pp. 701-7, 1996.
, “Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 5, pp. 523-7, 1995.
, “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
, “Falciparum malaria in pregnancy”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 35, no. 4, pp. 468-9., 1995.
, “Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study”, PARASITOLOGY, vol. 110, no. Suppl. pp. S25-36, 1995.
, “Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients”, Bulletin of the World Health Organization, vol. 73, no. 5, pp. 631-42, 1995.
, “New antimalarials. A risk-benefit analysis”, DRUG SAFETY, vol. 12, no. 4, pp. 264-73, 1995.
, “Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins”, Parasite, vol. 2, no. 3, pp. 263-8, 1995.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
, “Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 6, pp. 660-4, 1995.
, “Artemisinin: large community studies”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88 Suppl 1, pp. S45-6, 1994.
, “Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography”, American Journal of Tropical Medicine and Hygiene, vol. 51, no. 6, pp. 778-84, 1994.
, “Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 1. pp. 67-73, 1994.
, “Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study”, Journal of Infectious Diseases, vol. 169, no. 3, pp. 595-603, 1994.
, “Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 2, pp. 213-7, 1994.
, “Treatment of multidrug-resistant Plasmodium falciparum malaria with 3- day artesunate-mefloquine combination”, Journal of Infectious Diseases, vol. 170, no. 4, pp. 971-7, 1994.
, “Bed nets for the prevention of malaria and anaemia in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 6. pp. 620-6, 1993.
, “Cardiac effects of antimalarial treatment with halofantrine”, Lancet, vol. 341, pp. 1054-6, 1993.
, “Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria”, Lancet, vol. 341, pp. 1044-9, 1993.
, “Mefloquine prophylaxis”, Lancet, vol. 342, p. 551, 1993.
, “Single dose pharmacokinetics of proguanil and its metabolites in pregnancy”, European Journal of Clinical Pharmacology, vol. 44, no. 3, pp. 247-51, 1993.
, “Absorption of intramuscular phenobarbitone in children with severe falciparum malaria”, European Journal of Clinical Pharmacology, vol. 42, no. 1. pp. 107-10, 1992.
, “Comparison of artemether and chloroquine for severe malaria in Gambian children”, Lancet, vol. 339, pp. 317-21, 1992.
, “High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria”, Journal of Infectious Diseases, vol. 166, no. 6, pp. 1393-400, 1992.
, “Intracranial pressure in childhood cerebral malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 3, pp. 362-4, 1991.
, “Malaria during pregnancy in an area of unstable endemicity”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 4, pp. 424-9, 1991.
, “Mefloquine for multidrug-resistant malaria”, Lancet, vol. 338. p. 1268, 1991.
, “Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria”, British Journal of Clinical Pharmacology, vol. 31, no. 5, pp. 556-9, 1991.
, “Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study”, British Journal of Clinical Pharmacology, vol. 30, no. 1. pp. 79-85, 1990.
, “Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine”, Bulletin of the World Health Organization, vol. 65, no. 6. pp. 891-6, 1987.
,